CLDX vs. MAMA
CLDX (Celldex Therapeutics, Inc.) and MAMA (Mama's Creations Inc.) are both stocks. CLDX operates in Biotechnology (Healthcare), while MAMA operates in Packaged Foods (Consumer Defensive). Over the past 10 years, CLDX returned -6.50%/yr vs 41.84%/yr for MAMA. At a 0.05 correlation, their price movements are largely independent.
Performance
CLDX vs. MAMA - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, CLDX achieves a 23.01% return, which is significantly lower than MAMA's 34.40% return. Over the past 10 years, CLDX has underperformed MAMA with an annualized return of -6.50%, while MAMA has yielded a comparatively higher 41.84% annualized return.
CLDX
- 1D
- 3.02%
- 1M
- 8.72%
- YTD
- 23.01%
- 6M
- 22.52%
- 1Y
- 62.98%
- 3Y*
- -1.99%
- 5Y*
- 2.17%
- 10Y*
- -6.50%
MAMA
- 1D
- 2.03%
- 1M
- 22.42%
- YTD
- 34.40%
- 6M
- 32.24%
- 1Y
- 129.49%
- 3Y*
- 83.38%
- 5Y*
- 47.24%
- 10Y*
- 41.84%
CLDX vs. MAMA - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
CLDX Celldex Therapeutics, Inc. | 23.01% | 7.48% | -36.28% | -11.02% | 15.35% | 120.55% | 685.65% | -24.88% | -93.03% | -19.77% |
MAMA Mama's Creations Inc. | 34.40% | 69.47% | 62.12% | 173.54% | -10.70% | 12.29% | 47.93% | 75.36% | -46.92% | 80.56% |
Correlation
The correlation between CLDX and MAMA is 0.08, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.08 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.10 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.09 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.05 |
Correlation (All Time) Calculated using the full available price history since Jul 17, 2014 | 0.05 |
Fundamentals
CLDX:
$2.22B
MAMA:
$785.41M
CLDX:
-$4.27
MAMA:
$0.15
CLDX:
2.71K
MAMA:
3.98
CLDX:
4.87
MAMA:
14.19
CLDX:
$820.00K
MAMA:
$189.23M
CLDX:
$805.00K
MAMA:
$46.29M
CLDX:
-$216.32M
MAMA:
$11.97M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CLDX vs. MAMA — Risk / Return Rank
CLDX
MAMA
CLDX vs. MAMA - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Celldex Therapeutics, Inc. (CLDX) and Mama's Creations Inc. (MAMA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| CLDX | MAMA | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.29 | ||
| Sortino ratioReturn per unit of downside risk | -1.40 | ||
| Omega ratioGain probability vs. loss probability | 1.23 | 1.43 | -0.20 |
| Calmar ratioReturn relative to maximum drawdown | 2.61 | 5.42 | -2.80 |
| Martin ratioReturn relative to average drawdown | 6.76 | 13.31 | -6.56 |
Loading charts...
Drawdowns
CLDX vs. MAMA - Drawdown Comparison
The maximum CLDX drawdown since its inception was -99.73%, which is greater than MAMA's maximum drawdown of -89.83%. Use the drawdown chart below to compare losses from any high point for CLDX and MAMA.
Loading charts...
Drawdown Indicators
| CLDX | MAMA | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.73% | -89.83% | -9.90% |
Max Drawdown (1Y)Largest decline over 1 year | -24.23% | -24.05% | -0.18% |
Max Drawdown (3Y)Largest decline over 3 years | -70.84% | -42.54% | -28.30% |
Max Drawdown (5Y)Largest decline over 5 years | -73.11% | -64.79% | -8.32% |
Max Drawdown (10Y)Largest decline over 10 years | -97.90% | -79.35% | -18.55% |
Current DrawdownCurrent decline from peak | -94.11% | 0.00% | -94.11% |
Average DrawdownAverage peak-to-trough decline | -78.04% | -45.72% | -32.32% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 9.35% | 9.76% | -0.41% |
Volatility
CLDX vs. MAMA - Volatility Comparison
The current volatility for Celldex Therapeutics, Inc. (CLDX) is 11.62%, while Mama's Creations Inc. (MAMA) has a volatility of 21.92%. This indicates that CLDX experiences smaller price fluctuations and is considered to be less risky than MAMA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| CLDX | MAMA | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 11.62% | 21.92% | -10.30% |
Volatility (6M)Calculated over the trailing 6-month period | 38.03% | 35.33% | +2.70% |
Volatility (1Y)Calculated over the trailing 1-year period | 56.82% | 54.13% | +2.69% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 59.21% | 57.62% | +1.59% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 77.95% | 81.45% | -3.50% |
Dividends
CLDX vs. MAMA - Dividend Comparison
Neither CLDX nor MAMA has paid dividends to shareholders.
Financials
CLDX vs. MAMA - Financials Comparison
This section allows you to compare key financial metrics between Celldex Therapeutics, Inc. and Mama's Creations Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
CLDX and MAMA have a correlation of 0.08, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
MAMA has higher volatility (21.92%) compared to CLDX (11.62%). In terms of maximum drawdown, CLDX dropped -99.73% vs MAMA's -89.83%.
MAMA currently has the higher Sharpe Ratio (2.41 vs 1.12), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for CLDX and MAMA
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer